"Optimizing drug development in oncology by clinical trial simulation: Why ..."

Jocelyn Gal et al. (2018)

> Home

Details and statistics

DOI: 10.1093/BIB/BBX055

access: closed

type: Journal Article

metadata version: 2021-10-14

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/bib/GalMFSVCGTSPC18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bib/GalMFSVCGTSPC18
Jocelyn Gal, Gérard Milano, Jean-Marc Ferrero, Esma Saâda-Bouzid, Julien Viotti, Sylvie Chabaud, Paul Gougis, Christophe Le Tourneau, Renaud Schiappa, Agnes Paquet, Emmanuel Chamorey:
Optimizing drug development in oncology by clinical trial simulation: Why and how? Briefings Bioinform. 19(6): 1203-1217 (2018)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.